1. Companies

  2. Neurofix

Neurofix

Neurofix

Discovers and develops molecules for the treatment of pathologies of the central nervous system.
Launch date
Employees
2-10 people
Market cap
-
Enterprise valuation
AUD5—8m (Dealroom.co estimates Feb 2023.)
Company register number A37542834
Villamayor Castile and León (HQ), Salamanca Castile and León (founding location)
https://neurofixpharma.com/
https://www.linkedin.com/company/neurofix-pharma/https://play.google.com/store/apps/details?id=neurofix.fc.app

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2017201820192020202120222023
Revenues<1m-<1m-<1m<1m<1m
% growth5579 %-----334 %
EBITDA(<1m)(<1m)<1m(<1m)(<1m)(<1m)-
% EBITDA margin(99 %)-100 %-(4357 %)(5208 %)-
Profit(<1m)(<1m)<1m(<1m)(<1m)(<1m)-
% profit margin(75 %)-66 %-(226 %)(3148 %)-

Source: Dealroom estimates

    • Edit
DateInvestorsAmountRound

$250k

Debt

€900k

Seed
*

€750k

Seed
Total FundingAUD2.8m

Related Content

Recent News about Neurofix

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.